Ashland Bellefonte Cancer Center

(606) 836-0202

(800) 543-3728 (Toll Free)

Real People, Real Stories

Bob Matthews of Ashland, KY
Lymphoma

Bob Matthews of Ashland chose Doctor Kirti Jain......Read Story


Carla Pauley of Flatwoods, KY
Lymphoma

It all started when Carla lost her mother...Read Story


Barbara Hogsten of Westwood, KY
Leukemia

Barbara has had a long battle with multiple medical....Read Story


Deborah McCabe of Ironton, OH
Breast Cancer

“There are 3 parts to cancer – the spiritual part, keeping....Read Story


Sally Lloyd of Ashland, KY
Exterior Squamous Cell Cancer

For almost 2 years Sally thought she had hemorrhoids....Read Story


Homer Waddle of Ironton, OH
Rectal Cancer

Two years ago on New Year's Eve...Read Story



Read Story


RadioImmunotherapy

Radioimmunotherapy is a new weapon in the fight against cancer. Zevalin is the first Radioimmunotherapy treatment to be approved by the Food and Drug Administration in the treatment of certain types of non-Hodgkins lymphoma.

Zevalin is different in many ways from conventional chemotherapy or external beam radiation therapy.

Radioimmunotherapy is a treatment that uses a radiation source, such as a radioisotope, with a component of the immune system, such as an antibody. Zevalin combines the cell targeting ability of a monoclonal antibody with the additional cell killing ability of a radioactive material called Yttrium-90.

The monoclonal antibody recognizes and attaches to a particular part of a B-Cell, called the CD20 antigen. This process allows Zevalin to specifically target B-cells, therefore destroying malignant NHL B-Cells.

Treatment can be completed within a week on an out-patient basis. This regime is generally well tolerated by the patients and can be given safely and effectively in a community cancer center.